Moreover, IGF-1 co-treatment reversed the reductions in GPX4 and SLC7A11 levels and the increase in ACSL4 levels in DHCR24-depleted NSCLC cells (Figure 4G,H). This evidence concerns the gene IGF1 and non-small cell lung carcinoma.